Arax Advisory Partners’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.13M | Buy |
7,966
+4,252
| +114% | +$1.18M | 0.06% | 262 |
|
|
2025
Q4 | $1.02M | Sell |
3,714
-2,508
| -40% | -$703K | 0.03% | 379 |
|
|
2025
Q3 | $1.79M | Buy |
6,222
+5,738
| +1,186% | +$1.7M | 0.03% | 498 |
|
|
2025
Q2 | $173K | Buy |
484
+190
| +65% | +$61.2K | 0.01% | 704 |
|
|
2025
Q1 | $96.9K | Buy |
294
+172
| +141% | +$51.8K | 0.01% | 730 |
|
|
2024
Q4 | $33.8K | Sell |
122
-517
| -81% | -$165K | ﹤0.01% | 1014 |
|
|
2024
Q3 | $222K | Buy |
639
+8
| +1% | +$2.75K | 0.02% | 328 |
|
|
2024
Q2 | $209K | Buy |
631
+594
| +1,605% | +$205K | 0.02% | 322 |
|
|
2024
Q1 | $13.6K | Hold |
37
| – | – | ﹤0.01% | 728 |
|
|
2023
Q4 | $11.2K | Sell |
37
-7
| -16% | -$2.05K | ﹤0.01% | 748 |
|
|
2023
Q3 | $12.7K | Hold |
44
| – | – | ﹤0.01% | 667 |
|
|
2023
Q2 | $12.4K | Sell |
44
-4
| -8% | -$1.04K | ﹤0.01% | 670 |
|
|
2023
Q1 | $12.3K | Hold |
48
| – | – | ﹤0.01% | 657 |
|
|
2022
Q4 | $15.9K | Hold |
48
| – | – | ﹤0.01% | 591 |
|
|
2022
Q3 | $13K | Buy |
48
+3
| +7% | +$844 | ﹤0.01% | 621 |
|
|
2022
Q2 | $12K | Buy |
45
+22
| +96% | +$5.67K | ﹤0.01% | 622 |
|
|
2022
Q1 | $6K | Sell |
23
-6
| -21% | -$1.41K | ﹤0.01% | 728 |
|
|
2021
Q4 | $7K | Buy |
29
+19
| +190% | +$4.04K | ﹤0.01% | 711 |
|
|
2021
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 838 |
|
|
2021
Q2 | $2K | Buy |
+10
| New | +$2.5K | ﹤0.01% | 837 |
|
|
2020
Q4 | $3K | Hold |
16
| – | – | ﹤0.01% | 643 |
|
|
2020
Q3 | $3K | Buy |
16
+10
| +167% | +$1.76K | ﹤0.01% | 621 |
|
|
2020
Q2 | $1K | Sell |
6
-5,279
| -100% | -$1M | ﹤0.01% | 647 |
|
|
2020
Q1 | $936K | Hold |
5,285
| – | – | 0.22% | 55 |
|
|
2019
Q4 | $1.08M | Hold |
5,285
| – | – | 0.31% | 35 |
|
|
2019
Q3 | $802K | Hold |
5,285
| – | – | 0.24% | 48 |
|
|
2019
Q2 | $833K | Buy |
+5,285
| New | +$828K | 0.28% | 42 |
|
|
2018
Q4 | $1M | Buy |
5,285
+3,429
| +185% | +$715K | 0.4% | 31 |
|
|
2018
Q3 | $387K | Buy |
1,856
+1,823
| +5,524% | +$338K | 0.16% | 74 |
|
|
2018
Q2 | $5K | Buy |
33
+7
| +27% | +$1.21K | ﹤0.01% | 382 |
|
|
2018
Q1 | $4K | Sell |
26
-92
| -78% | -$17.9K | ﹤0.01% | 387 |
|
|
2017
Q4 | $23K | Hold |
118
| – | – | 0.01% | 269 |
|
|
2017
Q3 | $22K | Buy |
118
+5
| +4% | +$890 | 0.01% | 268 |
|
|
2017
Q2 | $19K | Hold |
113
| – | – | 0.01% | 298 |
|
|
2017
Q1 | $16K | Sell |
113
-56
| -33% | -$8.25K | 0.01% | 299 |
|
|
2016
Q4 | $23K | Buy |
+169
| New | +$22.1K | 0.01% | 252 |
|
Other funds holding CI
VCM
VPM
Arax Advisory Partners's CI Position: Q1 2026 in Review
Arax Advisory Partners increased its Cigna (CI) stake by 114% in Q1 2026, buying an estimated $1.18M and bringing the position to 7,966 shares worth $2.13M. The position accounts for 0.06% of the portfolio, ranked #262.
Arax Advisory Partners first reported a position in CI in Q4 2016 and has held it in 36 quarters since. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Arax Advisory Partners held 7,966 shares of Cigna worth $2.13M as of Q1 2026.
- Arax Advisory Partners bought 4,252 Cigna shares in Q1 2026, an estimated $1.18M.
- Cigna made up 0.06% of Arax Advisory Partners's portfolio in Q1 2026, its #262 holding.
- Arax Advisory Partners first reported a position in Cigna in Q4 2016 and has held it in 36 quarters since.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.